Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

3 More FTSE 100 Shares That the Market Loves: Rexam PLC (REX)

LONDON — Before investing in a company, it’s important to gauge what the rest of the market thinks. This will help you understand what would be needed for the share price to move significantly.

City research analysts are paid to give their verdicts on listed companies. I’ve scanned the FTSE 100 to find the companies that have the highest proportion of positive recommendations issued against them by the analysts. Here are three more of the most popular shares on the market.

Shire is the smallest of the FTSE 100’s three pharmaceuticals companies. It has thrived from the sale of its attention deficit disorder treatments. A boom in diagnosis of this condition in developed countries has led sales to nearly double in the last five years. In that time, earnings per share has increased by an average of 30.1% per annum.

The company is expected to increase its dividend for 2012 by 30%, and that’s to be followed by a similar increase for 2013. The shares trade on a 2013 price-to-earnings ratio of 14.3 times expectations. That’s the lowest rating that the shares have been on since the financial crisis.

Rexam PLC
Rexam PLC (LON:REX) is a packaging company, specializing in cans for the soft-drinks industry. This is a business with significant economies of scale and predictable sales demand. These factors and Rexam’s modest valuation are the likely cause of the share’s popularity. The shares are up 7.9% so far in 2013.

Rexam announced final results earlier this week. The company reported EPS up 5% and dividends up 6%. Brokers are forecasting that Rexam will make EPS of 42.3 pence for 2013, rising to 45.4 pence for 2014. The dividend is expected to hit 20.5 pence in 2014, putting the shares on a yield for the year of 4.1%.

Schroders plc
Like those of many fund managers, Schroders plc‘ profits are geared to the health of the financial markets.

Schroders is forecast to report EPS of 128.5 pence for 2012, rising to 141.2 pence this year. This puts the shares on a slight P/E discount to the rest of the companies in the FTSE 100. Schroders shares trade on a forecast yield for 2012 of 2.9%, rising to 3.2% for 2013. Future movements in the markets will have a big effect on the company’s profits. If you expect the current bull market to continue, Schroders could be a very good bet indeed.

The article 3 More FTSE 100 Shares That the Market Loves originally appeared on and is written by David O’Hara.

David does not own shares in any of the above companies.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!